Human Programmed cell death protein 1 recombinant protein (PDCD1)

Reference:
Size

100ug, 50ug

Size

,

Brand

Product type

Host Species

Applications

,

Product nameHuman Programmed cell death protein 1 recombinant protein (PDCD1)
Uniprot IDQ15116
Uniprot linkhttp://www.uniprot.org/uniprot/Q15116
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVGSHHHHHH
Molecular weight20.04kDa
Protein delivered with Tag?Yes
Purity estimated80%
Buffer150 mM NaCl, 50 mM Tris-HCl, pH 7.5
FormLyophilized
Delivery conditionDry Ice
Delivery lead time in business days5-7
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypePartial
Aliases /SynonymspYNW1, CD279, PD1, SLEB2, HPD1
ReferencePX-P4028
NoteFor research use only

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Human Programmed cell death protein 1 recombinant protein (PDCD1)”

Your email address will not be published. Required fields are marked *

Related products

Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade
Biosimilar Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade PX-TA1312 400€
Camrelizumab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade
Biosimilar Camrelizumab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade PX-TA1445 300€
Gilvetmab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Gilvetmab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1467 400€
Tislelizumab Biosimilar – Anti-PDCD1, PD1,  CD279 mAb – Research Grade
Biosimilar Tislelizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1479 400€
Spartalizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Spartalizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1483 300€
Cetrelimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Cetrelimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1513 400€
Budigalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Budigalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1523 400€
Cemiplimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Cemiplimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1524 400€
Dostarlimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Dostarlimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1526 400€
Prolgolimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Prolgolimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1533 400€
Sintilimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Sintilimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1536 400€
Toripalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Toripalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1540 400€
Balstilimab  Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
Biosimilar Balstilimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade PX-TA1558 400€
Lodapolimab  Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade
Biosimilar Lodapolimab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade PX-TA1593 400€
Stable Isotope Labeled Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade
SIL Stable Isotope Labeled Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade PX-TA1004-SIL 1500€
CD121a Recombinant Protein
Receptor CD121a Recombinant Protein PX-P4101 406€
Dog Programmed death ligand 1(PDL1)-CD274 Recombinant Protein
Ligand Dog Programmed death ligand 1(PDL1)-CD274 Recombinant Protein PX-P3014 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.